Nadofaragene firadenovec: a new gold standard for BCG-unresponsive bladder cancer?

Article Details

Citation

Copy to clipboard

Kulkarni GS

Nadofaragene firadenovec: a new gold standard for BCG-unresponsive bladder cancer?

Lancet Oncol. 2021 Jan;22(1):8-9. doi: 10.1016/S1470-2045(20)30586-6. Epub 2020 Nov 27.

PubMed ID

33253640 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Nadofaragene firadenovec